Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Reference Pricing Clauses In US COVID-19 Contracts Leave Drug Industry Vulnerable

Feb 09 2021

• By Sarah Karlin-Smith

international flags — COVID-19 vaccine contracts contain international reference pricing clauses • Source: Shutterstock

Related Content

Exclusive Interview: Biopharma And A Biden Administration

Oct 26 2020

Trump’s Legacy Versus ‘March In’ Rights

Jan 23 2021

Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue

Nov 24 2020

Happy Holidays: ‘Most Favored Nation’ Rule Effective Date Likely To Be Delayed

Dec 22 2020

Coronavirus Update: Sanofi And GSK’s Vaccine Suffers Setback

Dec 11 2020

Coronavirus Update: After 'Warp Speed' Snub, Novavax Awarded US Military Vaccine Deal

Jun 05 2020

Operation Warp Speed Spreads Its Bets With $1.6bn Novavax Deal

Jul 07 2020

NIH Reluctant To “March In”: Collins Suggests Authority Not Intended To Address Pricing Concerns

Apr 20 2016

Related Companies

Sanofi

GSK plc

Novavax, Inc.

Inovio Pharmaceuticals, Inc.

Additional Topics

International United States Coronavirus COVID-19 Vaccines Pricing Debate Commercial Politics Reimbursement Policy BioPharmaceutical

More from Vaccines

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window